GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes

UW Pediatrics

UW Pediatrics first author	David Rawlings
	Et. al and additional authors
Publication Date	03/22/2024
Link to article	https://insight.jci.org/articles/view/171844
DOI	10.1172/jci.insight.171844
PMID	38516892
Journal name	JCI Insight